Engaging innate immunity for targeting the epidermal growth factor receptor: Therapeutic options leveraging innate immunity versus adaptive immunity versus inhibition of signaling.
Frontiers In Oncology
Hintzen, Gabriele G; Dulat, Holger J HJ; Rajkovic, Erich E
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers
Cserepes, Mihály M; Nelhűbel, Györgyi A GA; Meilinger-Dobra, Mónika M; Herczeg, Adrienn A; Türk, Dóra D; Hegedűs, Zita Z; Svajda, Laura L; Rásó, Erzsébet E; Ladányi, Andrea A; Csikó, Kristóf György KG; Kenessey, István I; Szöőr, Árpád Á; Vereb, György G; Remenár, Éva É; Tóvári, József J